Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Filgotinib alone or with methotrexate in methotrexate-naive active rheumatoid arthritis
MOH_2017-02-13_000117Phase 3Recruiting
- Sponsor
- Gilead Sciences
- Start
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of filgotinib in rheumatoid arthritis (RA) (4 arms), sponsored by Gilead Sciences. Primary endpoint: Week 24 clinical improvement assessment. Started Dec 2016; status: recruiting.
02
Drugs
filgotinib
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on MOH_2017-02-13_000117.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2017-02-13_000117.